Access Now: AORN COVID-19 Clinical Support

Home >  News >  August, 2013

FDA Says Recalled Stryker Device is Potentially Deadly

Spinal implant recall is now Class 1.

Published: August 30, 2013

The FDA has assigned its most serious label, Class 1, to Stryker's recall of its Midline Occiput Plate, indicating that a malfunctioning component of the spinal surgery device could have deadly consequences.

Stryker initiated the recall in May, after reports that the pin that connects the implant's tulip head to the plate body can fracture, potentially causing blood loss, nerve injury and the need for surgery to replace the fractured implant. In its announcement, Stryker urged medical facilities to examine inventory and immediately stop distributing or using the recalled device.

In a June 20 notification to spinal implant surgeons, Stryker recommended that they conduct routine clinical and radiographic post-operative evaluations on patients with the implanted device, with particular attention to those experiencing pain, weakness or numbness.

Jim Burger

Also in the News...

AORN Expo 2021 Moves to August
CMS Issues Updated Reopening Recommendations
4 Million Surgeries Canceled Due to COVID-19
When Can Vendor Reps Return to ORs?
Coronavirus Outbreak Reignites Feud Between Anesthesia Groups
Outpatient ORs Reopening for Business
HHS Clarifies Conditions for COVID-19 Grants

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You